Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 59


Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.

Atun R, Chang AY, Ogbuoji O, Silva S, Resch S, Hontelez J, Bärnighausen T.

BMJ Open. 2016 Mar 6;6(3):e009656. doi: 10.1136/bmjopen-2015-009656.


Crystal structure of 12-benzyl-sulfanyl-2,9-di-bromo-6H-dibenzo[b,g][1,8]naphthyridin-11-one.

Resch S, Quell T, Schollmeyer D, Waldvogel SR.

Acta Crystallogr E Crystallogr Commun. 2015 Aug 22;71(Pt 9):o675-6. doi: 10.1107/S2056989015014541. eCollection 2015 Sep 1.


Functionalization of Silver Nanowires Surface using Ag-C Bonds in a Sequential Reductive Method.

Bashouti MY, Resch S, Ristein J, Mačković M, Spiecker E, Waldvogel SR, Christiansen SH.

ACS Appl Mater Interfaces. 2015 Oct 7;7(39):21657-61. doi: 10.1021/acsami.5b06830. Epub 2015 Sep 25.


The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients.

Jiang Y, Resch S, Liu X, Rogers SO Jr, Askari R, Klompas M, Jayaraman SP.

Surg Infect (Larchmt). 2016 Jan;17(1):58-64. doi: 10.1089/sur.2015.036. Epub 2015 Sep 10.


Defeating AIDS--advancing global health.

Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M; UNAIDS–Lancet Commission.

Lancet. 2015 Jul 11;386(9989):171-218. doi: 10.1016/S0140-6736(15)60658-4. Epub 2015 Jun 24. Review. No abstract available. Erratum in: Lancet. 2015 Jul 11;386(9989):136.


Measuring and Comparing the Cost-Effectiveness of Surgical Care Delivery in Low-Resource Settings: Cleft Lip and Palate as a Model.

Hackenberg B, Ramos MS, Campbell A, Resch S, Finlayson SR, Sarma H, Howaldt HP, Caterson EJ.

J Craniofac Surg. 2015 Jun;26(4):1121-5. doi: 10.1097/SCS.0000000000001829.


Tracking financial flows for immunization in Honduras.

Valdés W, Janusz CB, Molina Aguilera IB, Mendoza L, Díaz IY, Resch S.

Vaccine. 2015 May 7;33 Suppl 1:A85-92. doi: 10.1016/j.vaccine.2015.01.012.


ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.

Jauregui B, Janusz CB, Clark AD, Sinha A, Garcia AG, Resch S, Toscano CM, Sanderson C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A21-7. doi: 10.1016/j.vaccine.2014.12.080.


Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.

Novaes HM, de Soárez PC, Silva GA, Ayres A, Itria A, Rama CH, Sartori AM, Clark AD, Resch S.

Vaccine. 2015 May 7;33 Suppl 1:A135-42. doi: 10.1016/j.vaccine.2014.12.031.


Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.

Resch S, Ryckman T, Hecht R.

Lancet Glob Health. 2015 Jan;3(1):e52-61. doi: 10.1016/S2214-109X(14)70342-0.


The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.

Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, Resch S, Freedberg KA, Peter T, Walensky RP.

PLoS Med. 2014 Sep 16;11(9):e1001725. doi: 10.1371/journal.pmed.1001725. eCollection 2014 Sep.


Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.

Gaul C, Resch S.

Cephalalgia. 2015 May;35(6):545-50. doi: 10.1177/0333102414550107. Epub 2014 Sep 12.


Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations.

Doherty K, Essajee S, Penazzato M, Holmes C, Resch S, Ciaranello A.

BMC Health Serv Res. 2014 May 2;14:201. doi: 10.1186/1472-6963-14-201.


Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization.

Castañeda-Orjuela C, Romero M, Arce P, Resch S, Janusz CB, Toscano CM, De la Hoz-Restrepo F.

Vaccine. 2013 Jul 2;31 Suppl 3:C72-9. doi: 10.1016/j.vaccine.2013.05.038. Review.


Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.

Toscano CM, Jauregui B, Janusz CB, Sinha A, Clark AD, Sanderson C, Resch S, Ruiz Matus C, Andrus JK; ProVac Network of Centers of Excellence.

Vaccine. 2013 Jul 2;31 Suppl 3:C12-8. doi: 10.1016/j.vaccine.2013.05.033.


Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.

Chen SC, Toy M, Yeh JM, Wang JD, Resch S.

Pediatrics. 2013 Apr;131(4):e1135-43. doi: 10.1542/peds.2012-1262. Epub 2013 Mar 25. Erratum in: Pediatrics. 2014 Feb;133(2):346.


Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.

Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM.

J Thromb Haemost. 2013 Jun;11(6):1032-42. doi: 10.1111/jth.12184.


Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R.

BMC Med. 2013 Jan 30;11:23. doi: 10.1186/1741-7015-11-23.


Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention.

Spaulding AC, Pinkerton SD, Superak H, Cunningham MJ, Resch S, Jordan AO, Yang Z.

AIDS Behav. 2013 Oct;17 Suppl 2:S220-6. doi: 10.1007/s10461-012-0353-4.


Economic returns to investment in AIDS treatment in low and middle income countries.

Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R.

PLoS One. 2011;6(10):e25310. doi: 10.1371/journal.pone.0025310. Epub 2011 Oct 5.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk